Q4 2019 Holdings
Filed 2020-02-13 | 20 holdings | $81.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $81.2M | 785,981 | 99.6% |
| 10X Genomics Inc.(TXG) | COM | 88025U109 | $136.2K | 1,786,431 | 0.2% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $70.7K | 1,500,631 | 0.1% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $25.2K | 462,903 | 0.0% |
| Shockwave Medical Inc(SWAVUSD) | COM | 82489T104 | $12.7K | 288,838 | 0.0% |
| Iveric Bio Inc(OPHTEUR) | COM | 46583P102 | $8.6K | 1,004,299 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $6.5K | 366,268 | 0.0% |
| Obseva SA | COM | H5861P103 | $6.0K | 1,573,639 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.3K | 922,514 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $4.6K | 474,015 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $4.5K | 114,876 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $4.4K | 383,620 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $3.2K | 1,486,676 | 0.0% |
| Forty Seven Inc(FTSVEUR) | COM | 34983P104 | $3.1K | 77,714 | 0.0% |
| Milestone Pharmaceuticals Inc(MIST) | COM | 59935V107 | $2.4K | 148,560 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $2.0K | 36,249 | 0.0% |
| Myovant Sciences Ltd | COM | G637AM102 | $1.2K | 76,768 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $1.1K | 41,235 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $230 | 659,087 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $227 | 32,211 | 0.0% |